Exploring AbbVie's dividend stability, this analysis delves into the company's financial performance. With a 4% dividend yield and recent acquisition of Allergan, AbbVie remains a major player in the market. Weighing up the pros and cons of investing in ABBV stock, this guide helps investors navigate the complexities of the pharmaceutical giant.